Description
An antiviral agent; inhibits influenza A, B, and C (IC50s = 0.013-0.48 µg/ml); inhibits a GS4071-resistant influenza strain (IC50 = 0.095 µg/ml) and RNA viruses (IC50s = 4.8-41 µg/ml); not active against DNA viruses; undergoes phosphoribosylation to form T-705-RTP, the active form; decreases the rate of mortality in influenza-infected mice when used at a dose of 200 mg/kg once daily; reduces the lung virus yield in a dose-dependent manner at doses ranging from 50-200 mg/kg per day in influenza-infected mice,
Formal name: 6-fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide
Synonyms: Favilavir|Favipiravir
Molecular weight: 157.1
CAS: 259793-96-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|DNA & RNA Polymerase Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Influenza||Research Area|Infectious Disease|Viral Diseases|West Nile Virus
